Follow
Cindy J. Bednasz
Cindy J. Bednasz
Assistant Director, Clinical Pharmacology, Quality Manager, Enhanced Pharmacodynamics, LLC
Verified email at epd-llc.com
Title
Cited by
Cited by
Year
Efavirenz therapeutic range in HIV-1 treatment naïve participants
CJ Bednasz, CS Venuto, Q Ma, ES Daar, PE Sax, MA Fischl, AC Collier, ...
Therapeutic drug monitoring 39 (6), 596, 2017
172017
Race/ethnicity and protease inhibitor use influence plasma tenofovir exposure in adults living with HIV-1 in AIDS Clinical Trials Group study A5202
CJ Bednasz, CS Venuto, Q Ma, ES Daar, PE Sax, MA Fischl, AC Collier, ...
Antimicrobial agents and chemotherapy 63 (4), 2019
122019
Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct‐Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications
CJ Bednasz, CS Venuto, Q Ma, GD Morse
Clinical pharmacology in drug development 6 (2), 135-139, 2017
62017
Recent advances in management of the HIV/HCV coinfected patient
CJ Bednasz, JR Sawyer, A Martinez, PG Rose, SS Sithole, HR Hamilton, ...
Future virology 10 (8), 981-997, 2015
52015
The system can't perform the operation now. Try again later.
Articles 1–4